- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06072209
Long-term Effects ReSet Your Mind - Mechanisms
Long-term Effects of an Online Intervention Targeting Depression and Reward Sensitivity - Predictors and Mechanisms of Treatment Success
See: ClinicalTrials.gov ID: NCT05402150
Relevant for this Paper:
This investigation aims to evaluate the stability of the effectiveness of different two-week online interventions in a four months follow-up regarding reward sensitivity, anhedonia and depression.
The authors will further investigate factors influencing treatment success regarding reward sensitivity. The investigators assume that the more depressive expectations and stress improve during our online intervention, the more change in reward insensitivity is experienced at follow-up. In addition, it is hypothesized that the more people engaged in physical activities and social encounters during the two-week online intervention, the more change in reward insensitivity is experienced at follow-up.
Study Overview
Status
Conditions
Detailed Description
See for main study: ClinicalTrials.gov ID: NCT05402150.
A possible maintaining role in depressive symptoms plays reward hyposensitivity. Therefore, treatments should include evidence-based psychological interventions that target and modify reward insensitivity. Prior research lacks studies investigating reward sensitivity as main outcome measure, especially in the web-based format. This is why this study investigated an online intervention with the following groups regarding effectively increasing reward sensitivity compared to a waitlist control condition:
a) mindfulness-based interventions, b) behavioral activation, c) a combination of both.
The daily exercises were supported via videos and worksheets. Here, the investigators explore the effects after a four-months follow-up. In addition, this paper will deal with the long-term prediction of reward sensitivity, a feature not considered in our main paper preregistered with the ID NCT05402150. Factors, which are considered to play a big role in reward sensitivity are perceived stress, depressive expectations, physical activity and the frequency of social encounters.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Marburg, Germany, 35037
- Philipps University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 or above
- Fluent in German
- Informed consent
- Depressive symptoms (PHQ-9 > 5)
Exclusion Criteria:
- suicidality, severe depression
- current or lifetime: substance use disorder, psychotic disorders, bipolar I or II
- current psychotherapy
- if antidepressant medication: has not been stable over the last 4 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Behavioral Activation
14 days of daily excercises
|
- instruction to create a list of individual positive activities.
- instruction to include daily positive activities and fill out a mood protocol, which covers the time period shortly before, during and after the activity.
|
|
Experimental: Mindfulness and Gratitude
14 days of daily excercises
|
- instruction to fill out a mindfulness diary: reflection of daily pleasant situation, instructing the participants to revisit the impressions of their 5 senses during this situation, in addition they should specify how long they have actually dealt with
|
|
Experimental: Combination: Behavioral Activation and Mindfulness and Gratitude
14 days of daily excercises
|
This group will do a combination of the two intervention types.
|
|
No Intervention: Waitlist control group
Will receive the intervention (combination) after two weeks of intervention time of the other groups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptoms (Patient Health Questionnaire-9, PHQ-9)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Reward sensitivity (Positive Valence System Scale-21, PVSS-21)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Anhedonia (Snaith-Hamilton-Pleasure-Scale, SHAPS-D)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Change in Stress level (Perceived-Stress-Scale 10, PSS-10)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Change in Depressive Expectations (Depressive Expectations Scale, DES)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Amount of physical activity reported during intervention exercises
Time Frame: during intervention
|
- Type of activities and reflected pleasant situations that have been selected in the daily online surveys
|
during intervention
|
|
Amount of social encounters reported during intervention exercises
Time Frame: during intervention
|
- Type of activities and reflected pleasant situations that have been selected in the daily online surveys
|
during intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Personality traits (Big Five Inventory 10, BFI-10)
Time Frame: Baseline, post intervention (after 2 weeks), four months follow-up]
|
|
Baseline, post intervention (after 2 weeks), four months follow-up]
|
|
Adherence
Time Frame: post intervention (after 2 weeks), 4 months follow-up
|
|
post intervention (after 2 weeks), 4 months follow-up
|
|
Treatment expectation (Generic Rating for Treatment Pre-Experiences, Treatment Expectations, and Treatment Effects, G-EEE)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow-up
|
- Items range from 0 to 10 (depending on the item from "no improvement" to "greatest improvement imaginable", from "no worsening" to "greatest worsening imaginable", from "no complaints" to "greatest complaints imaginable") and one item, where previous treatment experience is assessed via a choice of "I have never experienced this treatment."
(continue with question 8), "I have experienced this treatment during the last 12 months (nearly) daily.",
"I have experienced this treatment during the last 12 months on more than 10 days.",
"I have experienced this treatment during the last 12 months on about 5 to 10 days.",
I have experienced this treatment during the last 12 months on about 1 to 4 days."
And "I have not experienced this treatment during the last 12 months, but I have experienced it before."
|
Baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Treatment credibility and expectancy (Credibility/Expectancy Questionnaire, CEQ)
Time Frame: Baseline
|
|
Baseline
|
|
Trait reward responsiveness (Reward Responsiveness Scale, RRS)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow-up
|
|
Baseline, post intervention (after 2 weeks), 4 months follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sociodemographic variables
Time Frame: baseline
|
- Gender, age, education, employment, medication, self report lifetime diagnosis of psychiatric conditions, previous experience with psychotherapy etc.
|
baseline
|
|
Perceived system usability (System usability Scale, SUS), general feedback about the online intervention
Time Frame: post intervention (after 2 weeks)
|
|
post intervention (after 2 weeks)
|
|
Problems and obstacles during the intervention
Time Frame: post intervention (after 2 weeks)
|
- Frequency of telephone contacts made with the principal contact person (Laura Potsch) and specified problems with the implementation of the daily excercises in the daily online survey
|
post intervention (after 2 weeks)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Winfried Rief, Prof. Dr., Dept. of Clinical Psychology and Psychotherapy, Philipps-University Marburg, Germany
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ReSet your Mind - Mechanisms
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression Moderate
-
Babes-Bolyai UniversityNorwegian University of Science and Technology; CheckWare ASCompleted
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Stanford UniversityRecruitingDepression | Depression Moderate | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression MildUnited States
-
University Hospital, ToulouseRecruitingDepression | Depression ModerateFrance
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; University of Tromso; Sussex Partnership... and other collaboratorsActive, not recruitingAnxiety | Mild to Moderate DepressionNorway
-
Norwegian Institute of Public HealthGöteborg University; University of Bergen; The Research Council of Norway; Sussex...Completed
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
National University of SingaporeRecruiting
-
Annecto LLCHoly Redeemer HospitalTerminatedMild to Moderate DepressionUnited States
Clinical Trials on Combination of Behavioral Activation and Mindfulness and Gratitude
-
Philipps University Marburg Medical CenterCompletedDepression Moderate | Depression MildGermany
-
Texas Tech UniversityRecruitingGrief | Mental Health Issue | Burden, CaregiverUnited States
-
Karolinska InstitutetCompletedDepression | Anxiety | Cancer SurvivorsSweden
-
Psychiatrische Dienste ThurgaugreenTEG AG; Brain2Go AG; SOMNOmedics GmbHCompletedFatigue | Depressive Disorder, Major | General PsychopathologySwitzerland
-
University of ChicagoTerminated
-
University of WashingtonMedical University of South Carolina; National Center for Complementary and... and other collaboratorsCompleted
-
University of ThessalyGreek Multiple Sclerosis Society; European Committee for Treatment and Research...Completed
-
University of OradeaYork UniversityRecruiting
-
University of FloridaWithdrawn
-
University of California, San DiegoNational Institute on Aging (NIA)CompletedDementia | Alzheimer Disease | Alzheimer's Disease | Alzheimer DementiaUnited States